Association Between the Antiplatelet Drug Efficacy/Safety and Platelet Function in Patients Treated With Novel Platelet Inhibitors Due to an Acute Coronary Syndrome

The aims of the study are to:

• explore whether platelet reactivity in patients treated wih novel platelet inhibitors is associated with clinical outcome
• investigate whether a therapeutic window exist for novel platelet inhibitors
• investigate the incidence of adverse events under treatment with novel platelet inhibitors in the real life clinical scenario
• investigate the association between genetic polymorphisms, inflammation, platelet reactivity and clinical outcome
• investigate synergistic effects between aspirin and novel platelet inhibitors